June 2018 – The CenterWatch Monthly : PDF
Industry Tries to Stem Investigator Dropout
Being a principal investigator (PI) is tough. So tough, in fact, that more than half of new investigators give up after their first FDA-regulated drug trial.
CRA/CRC Shortages Slow Clinical Trial Pace
As clinical trials continue to change, the evolving roles of CRAs and CRCs are exacerbating the problems sponsors and CROs have finding well-trained candidates.
Also in this issue:
- Assessing Cardiac Safety in Phase I
- Develop the Story Behind Your Asset
- Part One of Four: Are You Engaging Fake CRAs?
- Regulatory Update
- Month in Review
- FDA Actions
- Study Lead Opportunities
- New Drugs in the Pipeline